Welcome to Paid Research Studies




  • Condition:   Healthy Volunteers
    Interventions:   Drug: Vemlidy (tenofivir alafenamide);   Drug: Priftin (rifapentine);   Drug: Isoniazid;   Dietary Supplement: Pyridoxine
    Sponsor:   National Institutes of Health Clinical Center (CC)
    Recruiting

  • Condition:   Healthy Volunteers
    Interventions:   Drug: rifapentene (RPT);   Drug: darunavir/cobicistat (DRV/c);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine
    Sponsor:   National Institutes of Health Clinical Center (CC)
    Recruiting

  • Condition:   Tuberculosis, Pulmonary
    Interventions:   Drug: Azacitidine Injection [Vidaza] - Phase A Group;   Drug: Azacitidine Injection [Vidaza] - Phase B Group;   Drug: Azacitidine Injection [Vidaza] - Phase C Group;   Drug: Azacitidine Injection [Vidaza] - Phase D Group
    Sponsors:   Andrew Dinardo;   Celgene Corporation
    Not yet recruiting

  • Condition:   Latent Tuberculosis
    Interventions:   Drug: Rifapentine daily for 6 weeks;   Drug: Rifapentine and Isoniazid weekly for 12 weeks;   Drug: Rifampin and Isoniazid daily for 12 weeks;   Drug: Rifampin daily for 16 weeks
    Sponsors:   Centers for Disease Control and Prevention;   British Medical Research Council
    Recruiting

  • Conditions:   Tuberculosis;   Latent Tuberculosis Infection
    Interventions:   Other: Video Directly Observed Therapy;   Other: In-Person DOT
    Sponsor:   University of California, San Diego
    Recruiting

  • Condition:   HIV Infections
    Interventions:   Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting